V. Segarra et al., PHOSPHODIESTERASE INHIBITORY PROPERTIES OF LOSARTAN - DESIGN AND SYNTHESIS OF NEW LEAD COMPOUNDS, Bioorganic & medicinal chemistry letters, 8(5), 1998, pp. 505-510
A 4-centre PDE 4 pharmacophore search has been carried out in several
3D-databases containing compounds belonging to different therapeutic a
reas. Losartan, an angiotensin-II antagonist, has been identified as a
new lead compound for developping PDE 4 inhibitors. New families of c
ompounds derived from losartan has been synthesized and their PDE inhi
bition has been measured. (C) 1998 Elsevier Science Ltd. All rights re
served.